Cargando…

Atrial epicardial adipose tissue abundantly secretes myeloperoxidase and activates atrial fibroblasts in patients with atrial fibrillation

BACKGROUND: Epicardial adipose tissue (EAT) secretome induces fibrosis. Fibrosis, primarily extracellular matrix (ECM) produced by fibroblasts, creates a substrate for atrial fibrillation (AF). Whether the EAT secretome from patients with AF activates human atrial fibroblasts and through which compo...

Descripción completa

Detalles Bibliográficos
Autores principales: Meulendijks, Eva R., Al-Shama, Rushd F. M., Kawasaki, Makiri, Fabrizi, Benedetta, Neefs, Jolien, Wesselink, Robin, Ernault, Auriane C., Piersma, Sander, Pham, Thang V., Jimenez, Connie R., Knol, Jaco C., van Boven, Wim J. P., Driessen, Antoine H. G., de Vries, Tim A. C., van der Leeden, Britt, Niessen, Hans W. M., de Boer, Onno J., Krul, Sébastien P. J., de Groot, Joris R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10245533/
https://www.ncbi.nlm.nih.gov/pubmed/37280612
http://dx.doi.org/10.1186/s12967-023-04231-2
_version_ 1785054881998962688
author Meulendijks, Eva R.
Al-Shama, Rushd F. M.
Kawasaki, Makiri
Fabrizi, Benedetta
Neefs, Jolien
Wesselink, Robin
Ernault, Auriane C.
Piersma, Sander
Pham, Thang V.
Jimenez, Connie R.
Knol, Jaco C.
van Boven, Wim J. P.
Driessen, Antoine H. G.
de Vries, Tim A. C.
van der Leeden, Britt
Niessen, Hans W. M.
de Boer, Onno J.
Krul, Sébastien P. J.
de Groot, Joris R.
author_facet Meulendijks, Eva R.
Al-Shama, Rushd F. M.
Kawasaki, Makiri
Fabrizi, Benedetta
Neefs, Jolien
Wesselink, Robin
Ernault, Auriane C.
Piersma, Sander
Pham, Thang V.
Jimenez, Connie R.
Knol, Jaco C.
van Boven, Wim J. P.
Driessen, Antoine H. G.
de Vries, Tim A. C.
van der Leeden, Britt
Niessen, Hans W. M.
de Boer, Onno J.
Krul, Sébastien P. J.
de Groot, Joris R.
author_sort Meulendijks, Eva R.
collection PubMed
description BACKGROUND: Epicardial adipose tissue (EAT) secretome induces fibrosis. Fibrosis, primarily extracellular matrix (ECM) produced by fibroblasts, creates a substrate for atrial fibrillation (AF). Whether the EAT secretome from patients with AF activates human atrial fibroblasts and through which components, remains unexplored. RESEARCH AIMS: (a) To investigate if the EAT secretome from patients with versus without AF increases ECM production in atrial fibroblasts. (b) To identify profibrotic proteins and processes in the EAT secretome and EAT from patients with, who will develop (future onset), and without AF. METHODS: Atrial EAT was obtainded during thoracoscopic ablation (AF, n = 20), or open-heart surgery (future onset and non-AF, n = 35). ECM gene expression of human atrial fibroblasts exposed to the EAT secretome and the proteomes of EAT secretome and EAT were assessed in patients with and without AF. Myeloperoxidase and neutrophil extracellular traps (NETs) were assessed immunohistochemically in patients with paroxysmal, persistent, future onset, and those who remain free of AF (non-AF). RESULTS: The expression of COL1A1 and FN1 in fibroblasts exposed to secretome from patients with AF was 3.7 and 4.7 times higher than in patients without AF (p < 0.05). Myeloperoxidase was the most increased protein in the EAT secretome and EAT from patients with versus without AF (FC 18.07 and 21.57, p < 0.005), as was the gene-set neutrophil degranulation. Immunohistochemically, myeloperoxidase was highest in persistent (FC 13.3, p < 0.0001) and increased in future onset AF (FC 2.4, p = 0.02) versus non-AF. Myeloperoxidase aggregated subepicardially and around fibrofatty infiltrates. NETs were increased in patients with persistent versus non-AF (p = 0.03). CONCLUSION: In AF, the EAT secretome induces ECM gene expression in atrial fibroblasts and contains abundant myeloperoxidase. EAT myeloperoxidase was increased prior to AF onset, and both myeloperoxidase and NETs were highest in persistent AF, highlighting the role of EAT neutrophils in the pathophysiology of AF. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12967-023-04231-2.
format Online
Article
Text
id pubmed-10245533
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-102455332023-06-08 Atrial epicardial adipose tissue abundantly secretes myeloperoxidase and activates atrial fibroblasts in patients with atrial fibrillation Meulendijks, Eva R. Al-Shama, Rushd F. M. Kawasaki, Makiri Fabrizi, Benedetta Neefs, Jolien Wesselink, Robin Ernault, Auriane C. Piersma, Sander Pham, Thang V. Jimenez, Connie R. Knol, Jaco C. van Boven, Wim J. P. Driessen, Antoine H. G. de Vries, Tim A. C. van der Leeden, Britt Niessen, Hans W. M. de Boer, Onno J. Krul, Sébastien P. J. de Groot, Joris R. J Transl Med Research BACKGROUND: Epicardial adipose tissue (EAT) secretome induces fibrosis. Fibrosis, primarily extracellular matrix (ECM) produced by fibroblasts, creates a substrate for atrial fibrillation (AF). Whether the EAT secretome from patients with AF activates human atrial fibroblasts and through which components, remains unexplored. RESEARCH AIMS: (a) To investigate if the EAT secretome from patients with versus without AF increases ECM production in atrial fibroblasts. (b) To identify profibrotic proteins and processes in the EAT secretome and EAT from patients with, who will develop (future onset), and without AF. METHODS: Atrial EAT was obtainded during thoracoscopic ablation (AF, n = 20), or open-heart surgery (future onset and non-AF, n = 35). ECM gene expression of human atrial fibroblasts exposed to the EAT secretome and the proteomes of EAT secretome and EAT were assessed in patients with and without AF. Myeloperoxidase and neutrophil extracellular traps (NETs) were assessed immunohistochemically in patients with paroxysmal, persistent, future onset, and those who remain free of AF (non-AF). RESULTS: The expression of COL1A1 and FN1 in fibroblasts exposed to secretome from patients with AF was 3.7 and 4.7 times higher than in patients without AF (p < 0.05). Myeloperoxidase was the most increased protein in the EAT secretome and EAT from patients with versus without AF (FC 18.07 and 21.57, p < 0.005), as was the gene-set neutrophil degranulation. Immunohistochemically, myeloperoxidase was highest in persistent (FC 13.3, p < 0.0001) and increased in future onset AF (FC 2.4, p = 0.02) versus non-AF. Myeloperoxidase aggregated subepicardially and around fibrofatty infiltrates. NETs were increased in patients with persistent versus non-AF (p = 0.03). CONCLUSION: In AF, the EAT secretome induces ECM gene expression in atrial fibroblasts and contains abundant myeloperoxidase. EAT myeloperoxidase was increased prior to AF onset, and both myeloperoxidase and NETs were highest in persistent AF, highlighting the role of EAT neutrophils in the pathophysiology of AF. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12967-023-04231-2. BioMed Central 2023-06-06 /pmc/articles/PMC10245533/ /pubmed/37280612 http://dx.doi.org/10.1186/s12967-023-04231-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Meulendijks, Eva R.
Al-Shama, Rushd F. M.
Kawasaki, Makiri
Fabrizi, Benedetta
Neefs, Jolien
Wesselink, Robin
Ernault, Auriane C.
Piersma, Sander
Pham, Thang V.
Jimenez, Connie R.
Knol, Jaco C.
van Boven, Wim J. P.
Driessen, Antoine H. G.
de Vries, Tim A. C.
van der Leeden, Britt
Niessen, Hans W. M.
de Boer, Onno J.
Krul, Sébastien P. J.
de Groot, Joris R.
Atrial epicardial adipose tissue abundantly secretes myeloperoxidase and activates atrial fibroblasts in patients with atrial fibrillation
title Atrial epicardial adipose tissue abundantly secretes myeloperoxidase and activates atrial fibroblasts in patients with atrial fibrillation
title_full Atrial epicardial adipose tissue abundantly secretes myeloperoxidase and activates atrial fibroblasts in patients with atrial fibrillation
title_fullStr Atrial epicardial adipose tissue abundantly secretes myeloperoxidase and activates atrial fibroblasts in patients with atrial fibrillation
title_full_unstemmed Atrial epicardial adipose tissue abundantly secretes myeloperoxidase and activates atrial fibroblasts in patients with atrial fibrillation
title_short Atrial epicardial adipose tissue abundantly secretes myeloperoxidase and activates atrial fibroblasts in patients with atrial fibrillation
title_sort atrial epicardial adipose tissue abundantly secretes myeloperoxidase and activates atrial fibroblasts in patients with atrial fibrillation
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10245533/
https://www.ncbi.nlm.nih.gov/pubmed/37280612
http://dx.doi.org/10.1186/s12967-023-04231-2
work_keys_str_mv AT meulendijksevar atrialepicardialadiposetissueabundantlysecretesmyeloperoxidaseandactivatesatrialfibroblastsinpatientswithatrialfibrillation
AT alshamarushdfm atrialepicardialadiposetissueabundantlysecretesmyeloperoxidaseandactivatesatrialfibroblastsinpatientswithatrialfibrillation
AT kawasakimakiri atrialepicardialadiposetissueabundantlysecretesmyeloperoxidaseandactivatesatrialfibroblastsinpatientswithatrialfibrillation
AT fabrizibenedetta atrialepicardialadiposetissueabundantlysecretesmyeloperoxidaseandactivatesatrialfibroblastsinpatientswithatrialfibrillation
AT neefsjolien atrialepicardialadiposetissueabundantlysecretesmyeloperoxidaseandactivatesatrialfibroblastsinpatientswithatrialfibrillation
AT wesselinkrobin atrialepicardialadiposetissueabundantlysecretesmyeloperoxidaseandactivatesatrialfibroblastsinpatientswithatrialfibrillation
AT ernaultaurianec atrialepicardialadiposetissueabundantlysecretesmyeloperoxidaseandactivatesatrialfibroblastsinpatientswithatrialfibrillation
AT piersmasander atrialepicardialadiposetissueabundantlysecretesmyeloperoxidaseandactivatesatrialfibroblastsinpatientswithatrialfibrillation
AT phamthangv atrialepicardialadiposetissueabundantlysecretesmyeloperoxidaseandactivatesatrialfibroblastsinpatientswithatrialfibrillation
AT jimenezconnier atrialepicardialadiposetissueabundantlysecretesmyeloperoxidaseandactivatesatrialfibroblastsinpatientswithatrialfibrillation
AT knoljacoc atrialepicardialadiposetissueabundantlysecretesmyeloperoxidaseandactivatesatrialfibroblastsinpatientswithatrialfibrillation
AT vanbovenwimjp atrialepicardialadiposetissueabundantlysecretesmyeloperoxidaseandactivatesatrialfibroblastsinpatientswithatrialfibrillation
AT driessenantoinehg atrialepicardialadiposetissueabundantlysecretesmyeloperoxidaseandactivatesatrialfibroblastsinpatientswithatrialfibrillation
AT devriestimac atrialepicardialadiposetissueabundantlysecretesmyeloperoxidaseandactivatesatrialfibroblastsinpatientswithatrialfibrillation
AT vanderleedenbritt atrialepicardialadiposetissueabundantlysecretesmyeloperoxidaseandactivatesatrialfibroblastsinpatientswithatrialfibrillation
AT niessenhanswm atrialepicardialadiposetissueabundantlysecretesmyeloperoxidaseandactivatesatrialfibroblastsinpatientswithatrialfibrillation
AT deboeronnoj atrialepicardialadiposetissueabundantlysecretesmyeloperoxidaseandactivatesatrialfibroblastsinpatientswithatrialfibrillation
AT krulsebastienpj atrialepicardialadiposetissueabundantlysecretesmyeloperoxidaseandactivatesatrialfibroblastsinpatientswithatrialfibrillation
AT degrootjorisr atrialepicardialadiposetissueabundantlysecretesmyeloperoxidaseandactivatesatrialfibroblastsinpatientswithatrialfibrillation